RaQualia Pharma Inc.
4579ラクオリア創薬株式会社
Latest half-year results
First half · fiscal year to 2026-12 · filed 2026-08-14For the first half of the fiscal year to 2026-12: Ordinary income ¥-0.3 billion, Net income ¥-0.5 billion.
| This period | Year on year | |
|---|---|---|
| Ordinary profit | −¥326m | — |
| Net profit to owners | −¥467m | — |
From the securities report on EDINET, which states no forecast. History via /v1/companies/4579/earnings-releases.
Financials
Japan GAAP · consolidated · fiscal year to 2025-12-31- Revenue
- ¥4.0bn
- Net income
- ¥273m
- ROE
- 4.4%
- Equity ratio
- 65.1%
- Dividend / share
- —
- Employees
- 85
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | ¥4.0bn | ¥0.3bn | ¥10.5bn | ¥6.9bn | 4.4% | ¥11.53 | −¥0.4bn |
| 2024-12-31 | ¥3.1bn | −¥0.5bn | ¥9.7bn | ¥5.6bn | — | ¥-22.87 | ¥0.2bn |
| 2023-12-31 | ¥1.9bn | −¥0.3bn | ¥6.9bn | ¥6.1bn | — | ¥-14.98 | −¥0.7bn |
| 2022-12-31 | ¥2.9bn | ¥0.7bn | ¥6.3bn | ¥5.5bn | 14.1% | ¥34.5 | ¥1.5bn |
| 2021-12-31 | ¥2.8bn | ¥0.8bn | ¥5.2bn | ¥4.8bn | 17.2% | ¥36.07 | ¥0.4bn |
Indicators
Computed by us from filings · fiscal year to 2025-12-31| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | 4.4 | 21.3 |
| Ordinary margin | 0.11 | 71.8 |
| Equity ratio, % | 65.1 | 66.2 |
| Revenue growth | 0.2807 | 92.9 |
| Net income growth | 1.5517 | 90.5 |
| Operating cash flow / assets | -0.0337 | 10 |
Results wording balance: +0.33. Proprietary text method; it describes the wording only and does not interpret context.
Interest example: if all ¥2.7bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥13m. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.
Via /v1/companies/4579/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states themSegments, votes and tender offers
Stated in EDINET filings/v1/companies/4579/votingOwnership changes
All companies →- 2026-01-29
individual filer raised holdings in RaQualia Pharma Inc. (4579) to 25.11% from 20.35%.
- 2026-01-29
HK inno.N Corporation raised holdings in RaQualia Pharma Inc. (4579) to 25.11% from 20.35%.
- 2025-12-12
HK inno.N Corporation reduced holdings in RaQualia Pharma Inc. (4579) to 20.35% from 20.37%.
- 2025-12-12
individual filer reduced holdings in RaQualia Pharma Inc. (4579) to 20.35% from 20.37%.
- 2025-04-18
HK inno.N Corporation raised holdings in RaQualia Pharma Inc. (4579) to 20.37% from 11.38%.
- 2025-04-18
Holdings of HK inno.N Corporation in RaQualia Pharma Inc. (4579) moved above 20% (11.38% -> 20.37%).
- 2025-04-18
individual filer raised holdings in RaQualia Pharma Inc. (4579) to 20.37% from 11.38%.
- 2025-04-18
Holdings of individual filer in RaQualia Pharma Inc. (4579) moved above 20% (11.38% -> 20.37%).
- 2025-04-18
individual filer filed a correction to a 5% report on RaQualia Pharma Inc. (4579).
- 2025-03-31
Heights Capital Management, Inc. reduced holdings in RaQualia Pharma Inc. (4579) to 5.41% from 8.21%.
Trades by 5% holders
From the 60-day trade tables in 5% reports| Holder | Period | Net shares | Net % of shares | Avg. filed price | Range |
|---|---|---|---|---|---|
| エイチ・ケー・イノエン・コーポレーション | 2025-04-18 – 2026-01-29 | +4,148,000 | +16.59pt | ¥588.3 | ¥397–907 |
| Heights Capital Management, Inc. | 2023-01-05 – 2025-03-24 | +1,250,000 | +5.50pt | ¥831 | ¥404–1,258 |
Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4579/trades.
5% filings
Large shareholding reports on 4579| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2026-01-29 | individual filer | 25.11% | +4.76pt | — |
| 2026-01-29 | HK inno.N Corporation | 25.11% | +4.76pt | business alliance strategic holding |
| 2025-12-12 | HK inno.N Corporation | 20.35% | −0.02pt | business alliance strategic holding |
| 2025-12-12 | individual filer | 20.35% | −0.02pt | — |
| 2025-04-18 | HK inno.N Corporation | 20.37% | +8.99pt | business alliance strategic holding |
| 2025-04-18 | individual filer | 20.37% | +8.99pt | — |
| 2025-04-18 | individual filer | 20.37% | +8.99pt | — |
| 2025-03-31 | Heights Capital Management, Inc. | 5.41% | −2.80pt | pure investment |
| 2023-01-13 | Heights Capital Management, Inc. | 8.21% | — | pure investment |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- 1 issues
- Book value
- ¥54m
- Sold in the year
- — — issues
- Bought in the year
- — — issues
- Mutual, both reports
- 0
- Held by listed cos.
- 0
| Holds | Book value | Shares vs. prior year | Mutual |
|---|---|---|---|
| Elanco Animal Health Inc.（米国） | ¥54m | 0.0% | no |
Purposes, all holdings and mutual flags via /v1/companies/4579/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2025-12-31| Shareholder | Shares | Ratio |
|---|---|---|
| KOREA SECURITIES DEPOSITORY-SAMSUNG | 2,594,100 | 10.61% |
| individual holder | 2,384,700 | 9.75% |
| ファイザー株式会社 | 743,000 | 3.04% |
| モルガン・スタンレーMUFG証券株式会社 | 294,807 | 1.21% |
| 株式会社エス・ビー・シー | 251,300 | 1.03% |
| 株式会社アドバンスト・メディア | 223,800 | 0.92% |
| 東京短資株式会社 | 221,500 | 0.91% |
| individual holder | 169,500 | 0.69% |
| individual holder | 157,000 | 0.64% |
| 野村證券株式会社 | 156,798 | 0.64% |
Get this as JSON
GET /v1/companies/4579
GET /v1/companies/4579/financials
GET /v1/companies/4579/details
GET /v1/companies/4579/segments
GET /v1/companies/4579/voting
GET /v1/companies/4579/tender-offers
GET /v1/companies/4579/indicators
GET /v1/companies/4579/earnings-releases
GET /v1/events?ticker=4579
GET /v1/companies/4579/trades
GET /v1/companies/4579/cross-holdings
GET /v1/companies/4579/brief